Neuropsychiatric adverse effects following switch to vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: early experience from a regional centre
Neuropsychiatric adverse effects following switch to vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: early experience from a regional centre. // Journal of Cystic Fibrosis. – URL: https://www.sciencedirect.com/science/article/pii/S1569199326037434?dgcid=rss_sd_all
Neuropsychiatric adverse effects following switch to vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: early experience from a regional centre. Journal of Cystic Fibrosis. https://www.sciencedirect.com/science/article/pii/S1569199326037434?dgcid=rss_sd_all
“Neuropsychiatric adverse effects following switch to vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: early experience from a regional centre.” Journal of Cystic Fibrosis.
@article{article52891,
title = {Neuropsychiatric adverse effects following switch to vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: early experience from a regional centre},
journal = {Journal of Cystic Fibrosis},
url = {https://www.sciencedirect.com/science/article/pii/S1569199326037434?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...